Skip to main content
. 2021 Oct 1;28(6):925–932. doi: 10.1177/13524585211047223

Table 4.

Infection status by the lowest IgG titer in AQP4–IgG–seropositive participants receiving inebilizumab for ⩾4 years.

Titer, n (%) Infection status a Total (n = 75)
Yes (n = 60) No (n = 15)
Normal (⩾700 mg/dL) 26 (43.3) 9 (60.0) 35 (46.7)
Mild (500 to <700 mg/dL) 20 (33.3) 2 (13.3) 22 (29.3)
Moderate (300 to <500 mg/dL) 12 (20.0) 3 (20.0) 15 (20.0)
Severe (<300 mg/dL) 2 (3.3) 1 (6.7) 3 (4.0)

AQP4: aquaporin-4; Ig: immunoglobulin.

a

p = 0.3479 (Fisher’s exact test).